chr3-10328802-G-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001001331.4(ATP2B2):​c.*12C>G variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.292 in 1,596,812 control chromosomes in the GnomAD database, including 75,076 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.34 ( 9507 hom., cov: 29)
Exomes 𝑓: 0.29 ( 65569 hom. )

Consequence

ATP2B2
NM_001001331.4 3_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 0.256

Publications

16 publications found
Variant links:
Genes affected
ATP2B2 (HGNC:815): (ATPase plasma membrane Ca2+ transporting 2) The protein encoded by this gene belongs to the family of P-type primary ion transport ATPases characterized by the formation of an aspartyl phosphate intermediate during the reaction cycle. These enzymes remove bivalent calcium ions from eukaryotic cells against very large concentration gradients and play a critical role in intracellular calcium homeostasis. The mammalian plasma membrane calcium ATPase isoforms are encoded by at least four separate genes and the diversity of these enzymes is further increased by alternative splicing of transcripts. The expression of different isoforms and splice variants is regulated in a developmental, tissue- and cell type-specific manner, suggesting that these pumps are functionally adapted to the physiological needs of particular cells and tissues. This gene encodes the plasma membrane calcium ATPase isoform 2. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Jul 2008]
ATP2B2 Gene-Disease associations (from GenCC):
  • autosomal dominant nonsyndromic hearing loss
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • hearing loss, autosomal dominant 82
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • neurodevelopmental disorder
    Inheritance: AD Classification: STRONG Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.66).
BP6
Variant 3-10328802-G-C is Benign according to our data. Variant chr3-10328802-G-C is described in ClinVar as Benign. ClinVar VariationId is 1279072.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.569 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001001331.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ATP2B2
NM_001001331.4
MANE Select
c.*12C>G
3_prime_UTR
Exon 23 of 23NP_001001331.1Q01814-1
ATP2B2
NM_001438646.1
c.*12C>G
3_prime_UTR
Exon 21 of 21NP_001425575.1
ATP2B2
NM_001353564.1
c.*12C>G
3_prime_UTR
Exon 21 of 21NP_001340493.1Q01814-6

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ATP2B2
ENST00000360273.7
TSL:5 MANE Select
c.*12C>G
3_prime_UTR
Exon 23 of 23ENSP00000353414.2Q01814-1
ATP2B2
ENST00000452124.2
TSL:1
c.*12C>G
3_prime_UTR
Exon 20 of 20ENSP00000414854.2Q01814-8
ATP2B2
ENST00000397077.6
TSL:1
c.*12C>G
3_prime_UTR
Exon 20 of 20ENSP00000380267.1Q01814-6

Frequencies

GnomAD3 genomes
AF:
0.337
AC:
51074
AN:
151356
Hom.:
9493
Cov.:
29
show subpopulations
Gnomad AFR
AF:
0.441
Gnomad AMI
AF:
0.323
Gnomad AMR
AF:
0.337
Gnomad ASJ
AF:
0.246
Gnomad EAS
AF:
0.587
Gnomad SAS
AF:
0.499
Gnomad FIN
AF:
0.336
Gnomad MID
AF:
0.269
Gnomad NFE
AF:
0.251
Gnomad OTH
AF:
0.311
GnomAD2 exomes
AF:
0.344
AC:
84436
AN:
245646
AF XY:
0.343
show subpopulations
Gnomad AFR exome
AF:
0.445
Gnomad AMR exome
AF:
0.398
Gnomad ASJ exome
AF:
0.248
Gnomad EAS exome
AF:
0.590
Gnomad FIN exome
AF:
0.338
Gnomad NFE exome
AF:
0.249
Gnomad OTH exome
AF:
0.320
GnomAD4 exome
AF:
0.287
AC:
414710
AN:
1445338
Hom.:
65569
Cov.:
35
AF XY:
0.291
AC XY:
208362
AN XY:
715790
show subpopulations
African (AFR)
AF:
0.449
AC:
14868
AN:
33146
American (AMR)
AF:
0.386
AC:
17055
AN:
44216
Ashkenazi Jewish (ASJ)
AF:
0.243
AC:
6225
AN:
25592
East Asian (EAS)
AF:
0.624
AC:
24519
AN:
39322
South Asian (SAS)
AF:
0.469
AC:
39723
AN:
84674
European-Finnish (FIN)
AF:
0.344
AC:
18214
AN:
52916
Middle Eastern (MID)
AF:
0.277
AC:
1576
AN:
5698
European-Non Finnish (NFE)
AF:
0.250
AC:
274575
AN:
1100090
Other (OTH)
AF:
0.301
AC:
17955
AN:
59684
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.472
Heterozygous variant carriers
0
13962
27925
41887
55850
69812
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
9810
19620
29430
39240
49050
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.338
AC:
51139
AN:
151474
Hom.:
9507
Cov.:
29
AF XY:
0.346
AC XY:
25611
AN XY:
73994
show subpopulations
African (AFR)
AF:
0.442
AC:
18205
AN:
41204
American (AMR)
AF:
0.337
AC:
5134
AN:
15212
Ashkenazi Jewish (ASJ)
AF:
0.246
AC:
852
AN:
3466
East Asian (EAS)
AF:
0.587
AC:
2997
AN:
5108
South Asian (SAS)
AF:
0.496
AC:
2368
AN:
4778
European-Finnish (FIN)
AF:
0.336
AC:
3527
AN:
10512
Middle Eastern (MID)
AF:
0.276
AC:
81
AN:
294
European-Non Finnish (NFE)
AF:
0.251
AC:
17028
AN:
67894
Other (OTH)
AF:
0.311
AC:
652
AN:
2094
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1571
3143
4714
6286
7857
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
502
1004
1506
2008
2510
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.290
Hom.:
1305
Bravo
AF:
0.343
Asia WGS
AF:
0.527
AC:
1828
AN:
3478

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
not provided (2)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.66
CADD
Benign
5.9
DANN
Benign
0.79
PhyloP100
0.26
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs4327369; hg19: chr3-10370486; COSMIC: COSV59489676; COSMIC: COSV59489676; API